OXYVITA Inc. is a biotech company specializing in developing oxygen therapeutics and biomedical products utilizing our proprietary Zero-Linkā¢ hemoglobin polymerization process. OxyVita is a polymerized stroma free hemoglobin. This polymeric hemoglobin solution, which is clinically useful as a blood substitute due to its oxygen carrying function, can dramatically reduce the need for blood donated by human donors and significantly reduce the risks associated with blood transfusions. OXYVITA Inc. is now significantly advanced in preclinical trials and will be seeking to progress into clinical trials upon FDA approval. Current fund raising is geared at funding the remaining animal trials and FDA application endeavors. We continue to supply product to independent researchers for further evaluation of potential applications. OXYVITA Inc. had recently entered into a CRADA (Collaborative Research and Development Agreement with the U.S. Navy.
View Top Employees from OXYVITA Inc.Website | http://www.oxyvita.us |
Revenue | $5 million |
Employees | 4 (4 on RocketReach) |
Founded | 2000 |
Address | 108 World Trade Way, New Windsor, New York 12553, US |
Phone | (845) 774-9264 |
Technologies |
HTML,
PHP,
G Suite
+5 more
(view full list)
|
Industry | Biotechnology, Biotechnology Research, Pharmaceuticals, Science and Engineering, Healthcare |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 541 Companies, NAICS Code 54171 Companies, NAICS Code 5417 Companies, NAICS Code 54 Companies, NAICS Code 541713 Companies |
Looking for a particular OXYVITA Inc. employee's phone or email?
The OXYVITA Inc. annual revenue was $5 million in 2024.
Artur Wollocko is the Project Director of OXYVITA Inc..
4 people are employed at OXYVITA Inc..
OXYVITA Inc. is based in New Windsor, New York.
The NAICS codes for OXYVITA Inc. are [541, 54171, 5417, 54, 541713].
The SIC codes for OXYVITA Inc. are [87, 873].